Los Angeles Magazine has published its annual list of “Top Doctors” in Los Angeles and 29 UCLA Obstetrics and Gynecology physicians have been recognized in the 2021 guide as among the city’s best doctors. Congratulations to Drs. Yalda Afshar, Zain Al-Safi, Alexander Chiang, Joshua Cohen, Daniel Dumesic, Christina Han, Carla Janzen, Beth Karlan, Brian Koos, Deborah Krakow, Lindsay Kroener, Lydia Lee, Erin Mellano, Sanaz Memarzadeh, Tina A. Nguyen, Erica Oberman, Ram Parvataneni, Molly Quinn, Jeannine Rahimian, Ramneek Rana, Rashmi Rao, Valentina Rodriguez, Radhika Rible, Sulagna Saitta, Aparna Sridhar, Christopher Tarnay, Mya Zapata and Mae Zakhour. Learn more about Los Angeles Magazine’s “Top Doctors” list >
A vaccine is the most promising strategy for combating COVID-19 for the general population. For pregnant women there are two options – to get a vaccine when it’s available or to wait for more information about how the vaccine affects pregnant women. The American College of Obstetrician Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) recommend that COVID-19 vaccines should not be withheld from pregnant individuals who meet criteria for vaccination. UCLA OBGYN also stands by this statement from the ACOG and SMFM regarding the World Health Organization's position on this topic. Ultimately, it’s a decision that is best made in collaboration with your health care provider. Read more on the UCLA Health Connect Blog >
The BirthPlace Westwood and the BirthPlace Santa Monica are comprehensive maternity centers that provide private rooms, family-centered care and offer a wide range of services to make your birthing experience an event to cherish. More BirthPlace Information >
My Pregnancy: Weeks 1-20 >
My Pregnancy: Weeks 21-40 >
Giving to UCLA Obstetrics & Gynecology - UCLA OBGYN counts on your generous support to sustain our innovative programs, allowing us to provide exceptional gynecologic and obstetric health care for women by emphasizing the whole patient. Giving >
CERVICAL CANCER: The “Skyscraper-04” clinical trial is evaluating treatment options for cervical cancer. For this study, we are currently recruiting people who have recurrent (returned after previous treatment) cervical cancer. The purpose of this clinical trial is to evaluate the effects, good or bad, of tiragolumab plus atezolizumab and atezolizumab alone in patients with cervical cancer. For more details and enrollment information >
We in the UCLA Department of Obstetrics and Gynecology acknowledge and are deeply concerned regarding the disparities in the healthcare of women, particularly those of under-represented minorities. We recognize that the basis of this disparity is long-standing and sadly has its roots in racism and injustice against people of color, especially Black, Latino and Native American people. We concur with the statements released by other organizations that include National Medical Association (NMA), American College of Obstetricians and Gynecologists (ACOG), Society of Maternal-Fetal Medicine (SMFM), Society of Family Planning (SFP), and American Society of Reproductive Medicine (ASRM). We are committed as a department to identifying underlying implicit and explicit biases and eliminating them from our department in all areas including clinical service, research, and education.
We are also gravely troubled by the violence, discrimination, and stereotypes that have been inflicted upon Asian and Pacific Islanders (API) throughout our history, and recognize the recent escalations in these events. We stand with the API community to denounce hatred and racism in any form.
Schedule an appointment: 310-794-7274.
UCLA OBGYN wants you to know that we are doing everything possible to ensure your health and safety during this unusual time. Given the concerns about the spread of the novel Coronavirus (COVID-19), we are scheduling or rescheduling many clinic visits as “telemedicine visits,” which can be conducted from home.
Video visit information >